ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 275 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,428,000 | -0.5% | 100,238 | -4.2% | 0.03% | +4.0% |
| Q4 2021 | $2,441,000 | +39.2% | 104,598 | -0.9% | 0.02% | +47.1% |
| Q3 2021 | $1,754,000 | -35.1% | 105,575 | -4.7% | 0.02% | -37.0% |
| Q2 2021 | $2,703,000 | +74.7% | 110,806 | +84.8% | 0.03% | +68.8% |
| Q1 2021 | $1,547,000 | -52.1% | 59,952 | -0.8% | 0.02% | -56.8% |
| Q4 2020 | $3,232,000 | +26.6% | 60,450 | -2.3% | 0.04% | +8.8% |
| Q3 2020 | $2,552,000 | -26.6% | 61,862 | -13.7% | 0.03% | -30.6% |
| Q2 2020 | $3,476,000 | -20.2% | 71,706 | -30.4% | 0.05% | -32.9% |
| Q1 2020 | $4,355,000 | -5.4% | 103,076 | -4.2% | 0.07% | +23.7% |
| Q4 2019 | $4,604,000 | +18.1% | 107,610 | -0.7% | 0.06% | +9.3% |
| Q3 2019 | $3,900,000 | +33.9% | 108,356 | -0.6% | 0.05% | +31.7% |
| Q2 2019 | $2,912,000 | -0.4% | 108,959 | +0.1% | 0.04% | -2.4% |
| Q1 2019 | $2,924,000 | +69.1% | 108,888 | +1.8% | 0.04% | +44.8% |
| Q4 2018 | $1,729,000 | -48.0% | 106,915 | -33.3% | 0.03% | -38.3% |
| Q3 2018 | $3,326,000 | +32.0% | 160,215 | -2.9% | 0.05% | +27.0% |
| Q2 2018 | $2,519,000 | +2.6% | 164,951 | +51.0% | 0.04% | -2.6% |
| Q1 2018 | $2,455,000 | +71.4% | 109,264 | +129.7% | 0.04% | +72.7% |
| Q4 2017 | $1,432,000 | -20.2% | 47,564 | -0.2% | 0.02% | -24.1% |
| Q3 2017 | $1,795,000 | -14.3% | 47,651 | -36.5% | 0.03% | -19.4% |
| Q2 2017 | $2,094,000 | -21.5% | 75,066 | -3.3% | 0.04% | -23.4% |
| Q1 2017 | $2,668,000 | +17.1% | 77,607 | -1.8% | 0.05% | +9.3% |
| Q4 2016 | $2,279,000 | -7.5% | 79,011 | +2.0% | 0.04% | -12.2% |
| Q3 2016 | $2,464,000 | -2.0% | 77,457 | 0.0% | 0.05% | -9.3% |
| Q2 2016 | $2,514,000 | +16.1% | 77,457 | 0.0% | 0.05% | +12.5% |
| Q1 2016 | $2,166,000 | -22.1% | 77,457 | -0.6% | 0.05% | -22.6% |
| Q4 2015 | $2,779,000 | +8.4% | 77,957 | +0.6% | 0.06% | +1.6% |
| Q3 2015 | $2,563,000 | -21.0% | 77,491 | 0.0% | 0.06% | -14.1% |
| Q2 2015 | $3,245,000 | +28.5% | 77,491 | 0.0% | 0.07% | +29.1% |
| Q1 2015 | $2,525,000 | +100.2% | 77,491 | +95.1% | 0.06% | +96.4% |
| Q4 2014 | $1,261,000 | – | 39,715 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |